<DOC>
	<DOCNO>NCT01243567</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost/timolol fix combination ( GANfort® ) versus latanoprost ( Xalatan® ) patient open-angle glaucoma never previously treat high risk progression .</brief_summary>
	<brief_title>Safety Efficacy Bimatoprost/Timolol Fixed Combination Versus Latanoprost Patients With Open-Angle Glaucoma Who Have Never Been Treated</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis primary openangle glaucoma never treat Visual Acuity 20/60 good eye Eye surgery within 3 month Any refractive eye surgery Contraindication betaadrenoceptor antagonist therapy ( eg , chronic obstructive pulmonary disease [ COPD ] , bronchial asthma , sinus bradycardia , heart block , history severe myocardial infarction [ heart attack ] ) Eye inflammation eye infection within 3 month Eye trauma within 6 month Oral , injectable , topical ophthalmic steroid within 21 day anticipate use study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>